embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results
Embecta (Nasdaq: EMBC) has announced it will host a conference call on Thursday, November 26, 2024, at 8:00 a.m. ET to discuss its fiscal fourth quarter and full year 2024 financial results. The global diabetes care company will also provide an operational update and preliminary fiscal year 2025 financial guidance. Participants can access the event via live webcast or teleconference. A replay will be available from 11:00 a.m. ET on November 21, 2024, through the company's investor relations website for one year.
Embecta (Nasdaq: EMBC) ha annunciato che ospiterà una conferenza telefonica giovedì 26 novembre 2024, alle 8:00 ET, per discutere i suoi risultati finanziari del quarto trimestre fiscale e dell'intero anno 2024. L'azienda globale che si occupa di assistenza per il diabete fornirà anche un aggiornamento operativo e delle previsioni finanziarie preliminari per l'anno fiscale 2025. I partecipanti possono accedere all'evento tramite webcast in diretta o teleconferenza. Una registrazione sarà disponibile dalle 11:00 ET del 21 novembre 2024, sul sito web delle relazioni con gli investitori dell'azienda per un anno.
Embecta (Nasdaq: EMBC) ha anunciado que realizará una conferencia telefónica el jueves 26 de noviembre de 2024, a las 8:00 a.m. ET para discutir sus resultados financieros del cuarto trimestre fiscal y del año completo 2024. La empresa global de atención a la diabetes también proporcionará una actualización operativa y orientación financiera preliminar para el año fiscal 2025. Los participantes pueden acceder al evento a través de una transmisión web en vivo o teleconferencia. Una repetición estará disponible a partir de las 11:00 a.m. ET del 21 de noviembre de 2024, a través del sitio web de relaciones con inversores de la empresa durante un año.
엠벡타 (Nasdaq: EMBC)는 2024년 11월 26일 목요일 오전 8시 ET에 2024 회계 연도의 4분기 및 전체 재무 결과를 논의하기 위해 컨퍼런스 콜을 개최한다고 발표했습니다. 글로벌 당뇨병 관리 회사는 운영 업데이트와 2025 회계 연도에 대한 초기 재무 가이드라인도 제공합니다. 참가자는 라이브 웹캐스트 또는 전화 회의를 통해 이벤트에 액세스할 수 있습니다. 2024년 11월 21일 오전 11시 ET부터 회사의 투자자 관계 웹사이트에서 1년 동안 재생 가능합니다.
Embecta (Nasdaq: EMBC) a annoncé qu'elle tiendrait une conférence téléphonique le jeudi 26 novembre 2024, à 8h00 ET, pour discuter de ses résultats financiers du quatrième trimestre et de l'année fiscale 2024. L'entreprise mondiale spécialisée dans les soins au diabète fournira également une mise à jour opérationnelle et des prévisions financières préliminaires pour l'année fiscale 2025. Les participants peuvent accéder à l'événement via un webinaire en direct ou une téléconférence. Un enregistrement sera disponible à partir de 11h00 ET le 21 novembre 2024, sur le site web des relations investisseurs de l'entreprise pendant un an.
Embecta (Nasdaq: EMBC) hat angekündigt, dass am Donnerstag, den 26. November 2024, um 8:00 Uhr ET eine Telefonkonferenz stattfinden wird, um über die finanziellen Ergebnisse des vierten Quartals und des gesamten Jahres 2024 zu sprechen. Das globale Unternehmen für Diabetesversorgung wird außerdem ein operatives Update und eine vorläufige Finanzprognose für das Geschäftsjahr 2025 bereitstellen. Die Teilnehmer können die Veranstaltung über einen Live-Webcast oder eine Telefonkonferenz verfolgen. Eine Aufzeichnung wird ab dem 21. November 2024, 11:00 Uhr ET, über die Investor-Relations-Website des Unternehmens für ein Jahr verfügbar sein.
- None.
- None.
PARSIPPANY, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call to discuss its fiscal fourth quarter and full year 2024 financial results, and provide an operational update, including preliminary fiscal year 2025 financial guidance, at 8:00 a.m. Eastern Time (ET) on Thursday, November 26, 2024.
Those who would like to participate may access the live webcast here, or access the teleconference here. The live webcast can also be accessed via the company’s website at investors.embecta.com.
A webcast replay of the call will be available beginning at 11:00 a.m. ET on Nov 21, 2024, via the embecta investor relations website and archived on the website for one year.
About embecta
embecta is a global diabetes care company that is leveraging its 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solutions, partnerships and the passion of more than 2,000 employees around the globe. For more information, visit embecta.com or follow our social channels on LinkedIn, Facebook, and Instagram.
Contacts:
| Media | Investors |
| Christian Glazar | Pravesh Khandelwal |
| Sr. Director, Corporate Communications | VP, Head of Investor Relations |
| 908-821-6922 | 551-264-6547 |
| Contact Media Relations | Contact IR |
FAQ
When will Embecta (EMBC) report its Q4 and FY 2024 earnings?
Will Embecta (EMBC) provide FY 2025 guidance during its Q4 2024 earnings call?
How can investors access Embecta's (EMBC) Q4 2024 earnings call?
